Baird Financial Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.8M Buy
98,276
+225
+0.2% +$48.5K 0.03% 352
2025
Q4
$20.1M Sell
98,051
-1,218
-1% -$229K 0.03% 374
2025
Q3
$15.6M Sell
99,269
-124
-0.1% -$19.2K 0.03% 433
2025
Q2
$16.7M Buy
99,393
+51,416
+107% +$7.63M 0.03% 399
2025
Q1
$6.61M Sell
47,977
-1,763
-4% -$225K 0.01% 593
2024
Q4
$5.88M Sell
49,740
-239
-0.5% -$27.9K 0.01% 636
2024
Q3
$5.52M Sell
49,979
-7,654
-13% -$800K 0.01% 651
2024
Q2
$5.67M Sell
57,633
-33,439
-37% -$3.41M 0.01% 627
2024
Q1
$10.2M Sell
91,072
-2,061
-2% -$222K 0.02% 463
2023
Q4
$9.39M Buy
93,133
+1,319
+1% +$131K 0.02% 464
2023
Q3
$7.97M Sell
91,814
-2,874
-3% -$260K 0.02% 489
2023
Q2
$8.95M Buy
94,688
+19,166
+25% +$1.62M 0.02% 470
2023
Q1
$5.7M Sell
75,522
-9,741
-11% -$735K 0.01% 552
2022
Q4
$6.55M Buy
85,263
+8,154
+11% +$620K 0.02% 522
2022
Q3
$5.14M Sell
77,109
-479
-0.6% -$30.4K 0.02% 557
2022
Q2
$4.06M Sell
77,588
-1,990
-3% -$113K 0.01% 629
2022
Q1
$4.51M Buy
79,578
+432
+0.5% +$23.1K 0.01% 651
2021
Q4
$4.08M Buy
79,146
+18,069
+30% +$886K 0.01% 673
2021
Q3
$3.02M Buy
61,077
+1,705
+3% +$92.5K 0.01% 776
2021
Q2
$3.39M Buy
59,372
+463
+0.8% +$27.1K 0.01% 723
2021
Q1
$3.58M Buy
58,909
+1,497
+3% +$82.6K 0.01% 680
2020
Q4
$3.08M Buy
57,412
+1,853
+3% +$96.1K 0.01% 678
2020
Q3
$2.61M Buy
55,559
+1,689
+3% +$86.7K 0.01% 667
2020
Q2
$2.81M Buy
53,870
+5,536
+11% +$285K 0.01% 635
2020
Q1
$2.32M Buy
48,334
+41,118
+570% +$2.13M 0.01% 644
2019
Q4
$365K Sell
7,216
-16,769
-70% -$866K ﹤0.01% 1264
2019
Q3
$1.13M Buy
23,985
+1,499
+7% +$68.4K ﹤0.01% 940
2019
Q2
$1.06M Sell
22,486
-21,587
-49% -$996K ﹤0.01% 962
2019
Q1
$2.12M Sell
44,073
-13,450
-23% -$674K 0.01% 642
2018
Q4
$2.57M Buy
57,523
+10,108
+21% +$527K 0.02% 570
2018
Q3
$2.56M Sell
47,415
-134
-0.3% -$6.86K 0.02% 605
2018
Q2
$2.32M Buy
47,549
+4,881
+11% +$277K 0.02% 613
2018
Q1
$2.67M Sell
42,668
-8,446
-17% -$579K 0.02% 558
2017
Q4
$3.13M Sell
51,114
-28,296
-36% -$1.75M 0.02% 514
2017
Q3
$5.31M Buy
79,410
+14,981
+23% +$1.06M 0.04% 404
2017
Q2
$5.02M Sell
64,429
-11,250
-15% -$849K 0.04% 402
2017
Q1
$6.17M Buy
75,679
+11,797
+18% +$929K 0.05% 348
2016
Q4
$4.6M Sell
63,882
-32,511
-34% -$2.35M 0.04% 389
2016
Q3
$7.49M Buy
96,393
+2,447
+3% +$198K 0.07% 291
2016
Q2
$7.47M Buy
93,946
+11,157
+13% +$889K 0.07% 290
2016
Q1
$6.79M Sell
82,789
-173
-0.2% -$14.1K 0.06% 292
2015
Q4
$7.41M Buy
82,962
+4,245
+5% +$360K 0.07% 270
2015
Q3
$6.05M Buy
78,717
+12,366
+19% +$1.03M 0.06% 289
2015
Q2
$5.55M Buy
+66,351
New +$5.86M 0.05% 314

Other funds holding CAH

Baird Financial Group's CAH Position: Q1 2026 in Review

Baird Financial Group increased its Cardinal Health (CAH) stake by 0.23% in Q1 2026, buying an estimated $48.5K and bringing the position to 98,276 shares worth $20.8M. The position accounts for 0.03% of the portfolio, ranked #352.

Baird Financial Group first reported a position in CAH in Q2 2015 and has held it in 44 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Baird Financial Group held 98,276 shares of Cardinal Health worth $20.8M as of Q1 2026.
  • Baird Financial Group bought 225 Cardinal Health shares in Q1 2026, an estimated $48.5K.
  • Cardinal Health made up 0.03% of Baird Financial Group's portfolio in Q1 2026, its #352 holding.
  • Baird Financial Group first reported a position in Cardinal Health in Q2 2015 and has held it in 44 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.